HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fazio, S. Articles by Rall, S. C. Search for Related Content PubMed PubMed Citation Articles by Fazio, S. Articles by Rall, S. C., Jr Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 35, 408-416, Copyright © 1994 by Lipid Research, Inc.

ARTICLES

Altered lipoprotein metabolism in transgenic mice expressing low levels of a human receptor-binding-defective apolipoprotein E variant

S Fazio, Y Horie, WS Simonet, KH Weisgraber, JM Taylor and SC Rall Jr
Gladstone Institute of Cardiovascular Disease, University of California, San Francisco 94141-9100.

Transgenic mouse lines were produced that expressed low levels of a receptor-binding-defective variant of human apolipoprotein (apo) E, apoE(Arg112, Cys142). In transgenic mice, the human apoE was produced only by the kidney, whereas endogenous mouse apoE was produced mainly by the liver. The plasma concentration of the transgenic protein was about half that of endogenous apoE. The expression of transgenic apoE did not affect total plasma cholesterol and triglyceride levels, but the distribution of the human variant differed from that of endogenous apoE in the intermediate size and density range, where the transgenic protein accumulated selectively. Immunoblots of agarose gels of lipoprotein fractions showed that the transgenic protein occurred primarily on large alpha-migrating particles (HDL1). This phenomenon was not observed in transgenic mice expressing normal human apoE-3, which distributed like endogenous apoE, suggesting that the defective apoE variant perturbed HDL1 metabolism. In mice fed a high-fat, high- cholesterol diet, the transgenic apoE associated primarily with the apoB-containing lipoproteins. A significantly higher increase in very low density lipoprotein cholesterol was observed in fat-fed transgenics compared to fat-fed nontransgenic mice, suggesting a metabolic perturbation of apoB-containing lipoproteins. Thus, the receptor- binding-defective variant, apoE(Arg112, Cys142), expressed at low levels by the kidney, alters lipoprotein metabolism in transgenic mice, presumably by interfering with apoE-mediated removal of the lipoproteins from circulation.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. H. Hasty, M. F. Linton, S. J. Brandt, V. R. Babaev, L. A. Gleaves, and S. Fazio Retroviral Gene Therapy in ApoE-Deficient Mice : ApoE Expression in the Artery Wall Reduces Early Foam Cell Lesion Formation Circulation, May 18, 1999; 99(19): 2571 - 2576. [Abstract] [Full Text] [PDF]

				P. M. Sullivan, H. Mezdour, Y. Aratani, C. Knouff, J. Najib, R. L. Reddick, S. H. Quarfordt, and N. Maeda Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis J. Biol. Chem., July 18, 1997; 272(29): 17972 - 17980. [Abstract] [Full Text] [PDF]

				D. T. Berg, D. S. Calnek, and B. W. Grinnell Trans-repressor BEF-1 Phosphorylation J. Biol. Chem., March 1, 1996; 271(9): 4589 - 4592. [Abstract] [Full Text] [PDF]

				S. H. Zuckerman and N. Bryan-Poole Estrogen-Induced Alterations in Lipoprotein Metabolism in Autoimmune MRL/lpr Mice Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1556 - 1562. [Abstract] [Full Text]

				D. T. Berg, D. S. Calnek, and B. W. Grinnell The Human Apolipoprotein E Gene Is Negatively Regulated in Human Liver HepG2 Cells by the Transcription Factor BEF-1 J. Biol. Chem., June 30, 1995; 270(26): 15447 - 15450. [Abstract] [Full Text] [PDF]

				K. E. Kypreos, K. W. van Dijk, A. van der Zee, L. M. Havekes, and V. I. Zannis Domains of Apolipoprotein E Contributing to Triglyceride and Cholesterol Homeostasis in Vivo. CARBOXYL-TERMINAL REGION 203-299 PROMOTES HEPATIC VERY LOW DENSITY LIPOPROTEIN-TRIGLYCERIDE SECRETION J. Biol. Chem., June 1, 2001; 276(23): 19778 - 19786. [Abstract] [Full Text] [PDF]